New SEC Form D filing

ABVC BIOPHARMA, INC., 2026-11-10

A new SEC Form D private-offering notice from Fremont, CA, a $3,387,500 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

ABVC BIOPHARMA, INC. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing plant-derived drugs and medical devices for central nervous system disorders and oncology.

Filed 2026-11-10Filed to raise $3,387,500First money in 2026-10-30Raised so far $3,387,500HQ (as filed) Fremont, CASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Debt-only offering
Source linked the Form D on EDGAR↗Website verified abvcpharma.com↗Named in the filing 12 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source